Agenda*
Tuesday 23 September
07.30
Registration & Coffee
09.00
Opening Keynote
PriceWaterhouseCoopers
09.15
Public Markets & Finance Panel
Chair: Ms. Stephanie Léouzon, Managing Director Healthcare, Credit Suisse
Panellists:

Jean-Jacques Bienaimé, CEO, BioMarin Pharmaceuticals Inc.
Anne Ezendam, Director,Credit Suisse Asset Management
Sam Fazeli, Managing Director, Senior Biotechnology Analyst, Head of Equity Research, Piper Jaffray Ltd
Dr Yvonne Gunsch-Wegmann, Vice President, Head of Issuer & Investor Relations, SWX Swiss Exchange
Alexandra Goll, General Partner, TVM Capital
10.05
Private Equity & Venture Capital Panel
Chair: Steve Dickman, CEO, CBT Advisors
Panellists: Dr Bryan Morton, CEO, EUSA Pharma Inc
Dr Christina Takke, Principal, Forbion Capital Partners
Roel Bulthuis, Venture Capital Scouting, Merck Serono International
Reinhard J. Ambros, Managing Director, Novartis Venture Funds
Antoine Papiernik, Managing Partner, Sofinnova Partners
Dr Simon Turton, Managing Director Healthcare, Warburg Pincus LLC
11.00
Coffee Break
11.25
Company Presentations: Small-Cap Listed
13.05
Lunch
14.15
Company Presentations: Listed and Private Companies
17.00
Break
17.15
New Biology Discussion Panel
Chair: Steve Dickman, CEO, CBT Advisors
Panellists: Thomas Muster, CEO & CSO, AVIR Green Hills Biotechnology AG
Malcolm Weir, CEO, Heptares Therapeutics
Dr Christian Zahnd, CEO, Molecular Partners AG
Michael Gilman, CEO, Stromedix
18.30
Transport to Networking Dinner hosted by HBM
19.00 - 22.00
Sponsored Networking Dinner
 

 
Agenda*
Wednesday 24 September
07.30
Registration
09.00
Keynote – Trade Sale - The Route to Exit"
Dr Alexander Asam, Investment Advisor Private Equity Team, HBM Partners AG
09.20
Pharma Partnering Panel
Chair: Dimitri Dimitriou, Chief Executive Officer, DyoDelta Biosciences
Panellists: Lucien Cuvelier, NPI/Business Development Manager, Abbott Laboratories
Jose Maria Romero*, Vice President Transactions, Late-Stage Projects Worldwide Business Development, GlaxoSmithKline
David Lemus, CFO, MorphoSys AG
Esteban Pombo Villar, Head of Strategic Alliance Management EU, Novartis Pharma AG
Malcolm Bates, Partner, Taylor Wessing
10.05
Coffee Break
10.30

Sector Workshops:
Private Company Presentations

 
Early Stage Investment Discussion Panel
Followed by
Start-Up Company Presentations
13.00
Lunch
14.15
Sachs Associates
MEDTECH INVESTING FORUM
14.15
Medtech Investing Panel
Chair: Stan Yakatan, President, Katan Associates
Panellists:

TBC, BB Medtech
Dr Olivier Litzka, Partner Life Sciences, Edmond de Rothschild Investment Partners
Arthur L Franken, Partner, Gilde Healthcare Partners
Dr Jörg Neermann, Partner, Life Science Partners
15.00
Medtech Company Presentations
16.30 - 18.00
Networking Reception
Close of Conference

* subject to change

Back to top